Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
32.55
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
32.55
Bid (Size)
29.00 (1)
Ask (Size)
34.00 (10)
Prev. Close
32.55
Today's Range
32.55 - 32.55
52wk Range
15.81 - 41.06
Shares Outstanding
101,298,669
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Assessing Guardant Health: Insights From 7 Financial Analysts
July 17, 2024
Via
Benzinga
3 Biotech Moonshots With Imminent Catalyst Potential
July 03, 2024
Biotech has been one of the most explosive sectors. Better, further upside is likely, thanks to some of the top biotech stocks with catalysts.
Via
InvestorPlace
Performance
YTD
+22.78%
+22.78%
1 Month
+6.72%
+6.72%
3 Month
+98.60%
+98.60%
6 Month
+37.92%
+37.92%
1 Year
-14.07%
-14.07%
More News
Read More
The 3 Best Personalized Medicine Stocks to Buy in July 2024
July 03, 2024
Via
InvestorPlace
From ‘Sell’ to ‘Strong Buy’: 3 Dramatic Analyst U-Turns to Watch
July 02, 2024
Via
InvestorPlace
Where Guardant Health Stands With Analysts
June 28, 2024
Via
Benzinga
Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer
June 04, 2024
From
Guardant Health, Inc.
Via
Business Wire
Evaluating Guardant Health: Insights From 5 Financial Analysts
May 24, 2024
Via
Benzinga
Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials
June 03, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Named to TIME100 Most Influential Companies
May 31, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening
May 30, 2024
From
Guardant Health, Inc.
Via
Business Wire
Cathie Wood-LedArk Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
May 29, 2024
Via
Benzinga
Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns
May 27, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 27, 2024
Via
Benzinga
Deckers Outdoor Posts Upbeat Earnings, Joins Guardant Health, Ross Stores And Other Big Stocks Moving Higher On Friday
May 24, 2024
Via
Benzinga
FDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer Screening
May 24, 2024
Via
Benzinga
Exposures
Product Safety
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
May 24, 2024
Via
Investor's Business Daily
Exposures
Product Safety
FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option
May 23, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer Screening
May 23, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in Upcoming Investor Conferences
May 22, 2024
From
Guardant Health, Inc.
Via
Business Wire
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
May 21, 2024
Via
Benzinga
Exposures
Product Safety
Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
May 21, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week
May 16, 2024
From
Guardant Health, Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
May 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 10, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.